These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11841346)

  • 41. Requirement of the enzymatic and signaling activities of plasmin for phorbol-ester-induced scattering of colon cancer cells.
    Díaz VM; Hurtado M; Kort EJ; Resnati M; Blasi F; Thomson T; Paciucci R
    Exp Cell Res; 2006 Jul; 312(12):2203-13. PubMed ID: 16631161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Domain-dependent action of urokinase on smooth muscle cell responses.
    Tanski WJ; Fegley AJ; Roztocil E; Davies MG
    J Vasc Surg; 2004 Jan; 39(1):214-22. PubMed ID: 14718842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering.
    Gundersen D; Trân-Thang C; Sordat B; Mourali F; Rüegg C
    J Immunol; 1997 Feb; 158(3):1051-60. PubMed ID: 9013942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation and interactions in the activation of cell-associated plasminogen.
    Myöhänen H; Vaheri A
    Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular mechanisms regulating non-haemostatic plasmin generation.
    Bass R; Ellis V
    Biochem Soc Trans; 2002 Apr; 30(2):189-94. PubMed ID: 12023849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
    Czekay RP; Kuemmel TA; Orlando RA; Farquhar MG
    Mol Biol Cell; 2001 May; 12(5):1467-79. PubMed ID: 11359936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator.
    Frenette G; Tremblay RR; Lazure C; Dube JY
    Int J Cancer; 1997 May; 71(5):897-9. PubMed ID: 9180162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
    Stillfried GE; Saunders DN; Ranson M
    Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
    Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
    J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).
    Reinartz J; Link J; Todd RF; Kramer MD
    Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator.
    Schenk-Braat EA; Morser J; Rijken DC
    Eur J Biochem; 2001 Nov; 268(21):5562-9. PubMed ID: 11683879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The role of "growth" domain of urokinase in migration of smooth muscle cells].
    Stepanova VV; Goncharova EA; Bibilashvili RSh; Tkachuk VA
    Ross Fiziol Zh Im I M Sechenova; 1997; 83(11-12):158-67. PubMed ID: 9541968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator.
    Silva MM; Thelwell C; Williams SC; Longstaff C
    J Thromb Haemost; 2012 Nov; 10(11):2354-60. PubMed ID: 22974122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
    Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
    J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biotin-Chasing Assay to Evaluate uPAR Stability and Cleavage on the Surface of Cells.
    Leksa V; Schiller HB; Stockinger H
    Methods Mol Biol; 2018; 1731():39-47. PubMed ID: 29318541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.
    Reuning U; Magdolen V; Hapke S; Schmitt M
    Biol Chem; 2003 Aug; 384(8):1119-31. PubMed ID: 12974381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In silico docking of urokinase plasminogen activator and integrins.
    Degryse B; Fernandez-Recio J; Citro V; Blasi F; Cubellis MV
    BMC Bioinformatics; 2008 Mar; 9 Suppl 2(Suppl 2):S8. PubMed ID: 18387210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacterial plasminogen receptors: mediators of a multifaceted relationship.
    Sanderson-Smith ML; De Oliveira DM; Ranson M; McArthur JD
    J Biomed Biotechnol; 2012; 2012():272148. PubMed ID: 23118502
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Production and purification of urokinase: a comprehensive review.
    Bansal V; Roychoudhury PK
    Protein Expr Purif; 2006 Jan; 45(1):1-14. PubMed ID: 16055345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.